Zobrazeno 1 - 10
of 51
pro vyhledávání: '"A B, Rege"'
Autor:
B. Darpo, L. Sun, S. Yagoda, H. Xue, R. Brown, N. Nangia, D. McDonnell, B. Rege, L. Von Moltke
Publikováno v:
European Neuropsychopharmacology. 29:S507-S508
Publikováno v:
Alimentary Pharmacology & Therapeutics. 33:845-854
Aliment Pharmacol Ther 2011; 33: 845–854 Summary Background Novel rabeprazole extended-release (ER) formulations were developed to provide prolonged gastric acid suppression and potentially improved clinical outcomes in GERD patients. Aim To evalua
Publikováno v:
European Journal of Paediatric Neurology. 21:e32
Autor:
Vishram B. Rege, Michael Glantz, Plakyil Joseph, Wallace Akerley, Louis A. Leone, Loren Yee, Patti J. Wingate, Brigid Rodrigues, Hak Choy, Sundaresan Sambandam
Publikováno v:
Journal of Clinical Oncology. 16:153-158
PURPOSE We conducted a phase I study in chemotherapy-naive patients with advanced non-small-cell lung cancer (NSCLC) to determine the maximum-tolerated dose (MTD) of paclitaxel using an extended weekly schedule. PATIENTS AND METHODS Patients with sta
Autor:
Frank H. Valone, Stephen L. Graziano, Mark R. Green, Frederick Richards, Vishram B. Rege, Gerald H. Clamon, James E. Herndon, Jeffrey Crawford
Publikováno v:
Lung Cancer. 14:315-329
This Phase II study was designed to determine the efficacy of two chemotherapy regimens with G-CSF support for patients with advanced non-small cell lung cancer (NSCLC). One-hundred and one patients with Stage IIIB or IV NSCLC and performance status
Autor:
Juan J.L. Lertora, Arvind B. Rege, Nicholas Ferencz, William J. George, Maria G. Fuentes, Albert W. Dreisbach, Nancy Eddy Hopkins
Publikováno v:
Clinical Pharmacology & Therapeutics. 58:498-505
Objective To determine whether the urinary excretion of 6-hydroxychlorzoxazone is an index of CYP2E1 activity in vivo. Methods Male volunteers (n = 27; age range, 17 to 36 years) who were abstinent from alcohol were studied. Chlorzoxazone, 500 mg, wa
Autor:
Shiva Akula, Arvind B. Rege, Juan J.L. Lertora, William J. George, Newton E. Hyslop, Krishna C. Agrawal, Debra L. Greenspan
Publikováno v:
Clinical Pharmacology & Therapeutics. 56:272-278
Zidovudine is metabolized to an inactive 5'-glucuronide and has a short plasma half-life requiring frequent dosing. The present study in six patients without symptoms who were infected with human immunodeficiency virus was undertaken to determine if
Publikováno v:
Alimentary pharmacologytherapeutics. 33(7)
Novel rabeprazole extended-release (ER) formulations were developed to provide prolonged gastric acid suppression and potentially improved clinical outcomes in GERD patients.To evaluate the pharmacodynamics and pharmacokinetics of six rabeprazole-ER
Autor:
Gary M. Strauss, Caron Modeas, Mark R. Green, James E. Herndon, Douglas J. Mathisen, Noah C. Choi, David D. Sherman, Robert W. Carey, Vishram B. Rege
Publikováno v:
Journal of Clinical Oncology. 10:1237-1244
PURPOSE This phase II trial was designed to evaluate the feasibility, toxicity, response rates, and survival for neoadjuvant chemotherapy and radiotherapy (RT) followed by surgical resection in newly diagnosed patients with surgically staged IIIA non
Autor:
Newton E. Hyslop, William J. George, Juan J.L. Lertora, J. Y. Walker-Cador, R. A. Clark, Arvind B. Rege
Publikováno v:
Antimicrobial Agents and Chemotherapy. 36:647-650
Fluconazole, an orally active antifungal agent, has been shown to be clinically beneficial for maintenance therapy of cryptococcal meningitis. A sensitive gas-liquid chromatographic assay with electron capture detection, which required only a single